SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules.
Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.
Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their R&D goals
Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.
Tirbanibulin shows how ADME science, dermal delivery, and topical formulation development turn
skin drugs into real therapies. Read the full Syngene perspective now.
Explore how peptide conjugates are advancing veterinary oncology and pet therapeutics through targeted drug delivery. Discover emerging approaches today.
